GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,071,000 | -17.5% | 64,808 | -10.6% | 0.00% | 0.0% |
| Q1 2022 | $2,510,000 | -18.0% | 72,474 | -30.7% | 0.00% | -33.3% |
| Q4 2021 | $3,061,000 | +71.5% | 104,586 | +49.3% | 0.00% | +50.0% |
| Q3 2021 | $1,785,000 | -6.8% | 70,074 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,915,000 | -44.6% | 70,074 | -17.4% | 0.00% | -50.0% |
| Q1 2021 | $3,458,000 | -2.4% | 84,856 | +3.8% | 0.00% | 0.0% |
| Q4 2020 | $3,542,000 | -23.5% | 81,786 | -2.6% | 0.00% | -33.3% |
| Q3 2020 | $4,632,000 | -21.7% | 84,011 | -10.4% | 0.01% | -25.0% |
| Q2 2020 | $5,917,000 | +17.5% | 93,728 | -4.9% | 0.01% | -11.1% |
| Q1 2020 | $5,037,000 | -41.7% | 98,582 | -9.2% | 0.01% | -30.8% |
| Q4 2019 | $8,635,000 | +112.5% | 108,629 | +29.7% | 0.01% | +116.7% |
| Q3 2019 | $4,063,000 | +1.7% | 83,729 | +10.2% | 0.01% | 0.0% |
| Q2 2019 | $3,997,000 | +15.3% | 75,991 | +16.0% | 0.01% | +20.0% |
| Q1 2019 | $3,467,000 | +36.0% | 65,495 | +5.5% | 0.01% | +25.0% |
| Q4 2018 | $2,549,000 | +9.1% | 62,095 | +1.0% | 0.00% | +33.3% |
| Q3 2018 | $2,336,000 | +2.0% | 61,461 | +21.3% | 0.00% | 0.0% |
| Q2 2018 | $2,290,000 | -1.3% | 50,661 | +5.4% | 0.00% | -25.0% |
| Q1 2018 | $2,321,000 | +73.1% | 48,061 | +41.0% | 0.00% | +100.0% |
| Q4 2017 | $1,341,000 | – | 34,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |